| 000 | 01080 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517093648.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1741-7015 | ||
| 024 | 7 |
_a10.1186/s12916-016-0623-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarkona, Sofia | |
| 245 | 0 | 0 |
_aCancer immunotherapy: the beginning of the end of cancer? _h[electronic resource] |
| 260 |
_bBMC medicine _cMay 2016 |
||
| 300 |
_a73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aDiamandis, Eleftherios P | |
| 700 | 1 | _aBlasutig, Ivan M | |
| 773 | 0 |
_tBMC medicine _gvol. 14 _gp. 73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12916-016-0623-5 _zAvailable from publisher's website |
| 999 |
_c25993379 _d25993379 |
||